Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125007) titled 'Expression of DCXR in Breast Cancer and Its Clinicopathological Significance and Mechanisms' on May 20.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Fuding Hospital,Fujian University of Traditional Chinese Medicine
Condition:
Breast cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-04-01
Target Sample Size: Breast cancer group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307217
Published by HT Digital Content Services with permission from Health Daily Digest....